SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?


To: Ron Flanigan who wrote (202)5/3/1998 1:18:00 PM
From: kas1  Read Replies (1) | Respond to of 642
 
imagine you are running some institutional money. imagine you want to get that money into eli lilly, but

1) the stock has gotten away from you in terms of price; you wish you had bought it when it was 60 or so

and

2) you are running huge amounts of money; you cannot just place a buy order at market. there usually aren't enough sellers to take the other end of your stock acquisitions.

so you talk down a stock. you issue a downgrade, maybe leak a rumor that they'll miss the quarter. it drives the price down, and creates lots of willing sellers (hi volume) so you can acquire stock cheaply and without worries of making too big a splash in price action.

to what extent this is done is one of the great debates on si, and elsewhere. but everyone agrees that it is done sometimes.